Interaction of Drugs Candidates With Various SARS-CoV-2 Receptors: An in Silico Study to Combat COVID-19

doi 10.26434/chemrxiv.12100968.v3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Important Steps to Control COVID-19/SARS-CoV-2 Infection

SN Comprehensive Clinical Medicine
2020English

Detection of Antibodies Against SARS-CoV-2 in Patients With COVID-19

Journal of Medical Virology
VirologyInfectious Diseases
2020English

In Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors

2020English

A SARS-CoV-2/COVID-19 Em Pacientes Com Câncer

Revista Brasileira de Cancerologia
2020English

Hypothesis: Advanced Biotechnological Treatment Approaches Against SARS-CoV-2 (COVID-19)

Volume 5 - 2020, Issue 4 - April
2020English

Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients

2020English

COVID-19 Por SARS-CoV-2: La Nueva Emergencia De Salud

Revista Mexicana de Pediatria
Child HealthPediatricsPerinatology
2019English

In Silico Repositioning for Dual Inhibitor Discovery of SARS-CoV-2 (COVID-19) 3c-Like Protease and Papain-Like Peptidase

2020English

The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2)

Cytometry Part A
Forensic MedicinePathologyHistologyCell Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy